Physician profile

Gregg Rockower

Pediatrics · Nanuet, NY

NPI 1396819074

$409.54

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$143.42

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Sobi, INC $120.03 2019
Pfizer INC. $98.66 2022-2024
Merck Sharp & Dohme LLC $45.38 2019-2020
Glaxosmithkline, LLC. $45.20 2019
Cranial Technologies, INC $28.71 2019-2024 Doc Band
Kaleo, INC. $18.13 2023 Auvi-Q
Sanofi Pasteur INC. $14.89 2023
Abbvie INC. $13.93 2019
Regeneron Healthcare Solutions, INC. $13.33 2024 Dupixent
Astrazeneca Pharmaceuticals LP $11.28 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Gregg Rockower

$409.54

in general payments reported 2019-2025

Years
2019-2024
Top company
Sobi, INC

https://glasscript.com/doctor/199023/gregg-rockower

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.